Literature DB >> 30972526

The extracellular matrix in tumor progression and metastasis.

Johannes A Eble1, Stephan Niland2.   

Abstract

The extracellular matrix (ECM) constitutes the scaffold of tissues and organs. It is a complex network of extracellular proteins, proteoglycans and glycoproteins, which form supramolecular aggregates, such as fibrils and sheet-like networks. In addition to its biochemical composition, including the covalent intermolecular cross-linkages, the ECM is also characterized by its biophysical parameters, such as topography, molecular density, stiffness/rigidity and tension. Taking these biochemical and biophysical parameters into consideration, the ECM is very versatile and undergoes constant remodeling. This review focusses on this remodeling of the ECM under the influence of a primary solid tumor mass. Within this tumor stroma, not only the cancer cells but also the resident fibroblasts, which differentiate into cancer-associated fibroblasts (CAFs), modify the ECM. Growth factors and chemokines, which are tethered to and released from the ECM, as well as metabolic changes of the cells within the tumor bulk, add to the tumor-supporting tumor microenvironment. Metastasizing cancer cells from a primary tumor mass infiltrate into the ECM, which variably may facilitate cancer cell migration or act as barrier, which has to be proteolytically breached by the infiltrating tumor cell. The biochemical and biophysical properties therefore determine the rates and routes of metastatic dissemination. Moreover, primed by soluble factors of the primary tumor, the ECM of distant organs may be remodeled in a way to facilitate the engraftment of metastasizing cancer cells. Such premetastatic niches are responsible for the organotropic preference of certain cancer entities to colonize at certain sites in distant organs and to establish a metastasis. Translational application of our knowledge about the cancer-primed ECM is sparse with respect to therapeutic approaches, whereas tumor-induced ECM alterations such as increased tissue stiffness and desmoplasia, as well as breaching the basement membrane are hallmark of malignancy and diagnostically and histologically harnessed.

Entities:  

Keywords:  Cancer-associated fibroblast; Cell infiltration; Cell migration; Extracellular matrix; Invadopodia; Metastasis; Metastatic cascade; Metastatic niche; Tumor microenvironment; Tumor progression

Year:  2019        PMID: 30972526     DOI: 10.1007/s10585-019-09966-1

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  113 in total

1.  Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.

Authors:  Derek Hargrove; Brian Liang; Raana Kashfi-Sadabad; Gaurav N Joshi; Laura Gonzalez-Fajardo; Sterling Glass; Michael Jay; Andrew Salner; Xiuling Lu
Journal:  J Control Release       Date:  2020-11-07       Impact factor: 9.776

Review 2.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

Review 3.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

Review 4.  The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.

Authors:  Mark F Coughlin; Roger D Kamm
Journal:  Adv Healthc Mater       Date:  2020-01-29       Impact factor: 9.933

5.  Bioengineered Tumor Organoids.

Authors:  Anthony Dominijanni; Andrea Mazzocchi; Ethan Shelkey; Steven Forsythe; Mahesh Devarsetty; Shay Soker
Journal:  Curr Opin Biomed Eng       Date:  2020-04-01

6.  Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.

Authors:  Sung Soo Kim; Hwang Kyung Kim; Hanju Kim; Woo Tak Lee; Eun Seong Lee; Kyung Taek Oh; Han-Gon Choi; Yu Seok Youn
Journal:  Arch Pharm Res       Date:  2020-08-17       Impact factor: 4.946

Review 7.  Mutant p53 on the Path to Metastasis.

Authors:  Qiaosi Tang; Zhenyi Su; Wei Gu; Anil K Rustgi
Journal:  Trends Cancer       Date:  2019-12-16

Review 8.  The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers.

Authors:  Nina Kozlova; Joseph E Grossman; Marcin P Iwanicki; Taru Muranen
Journal:  Trends Pharmacol Sci       Date:  2020-01-31       Impact factor: 14.819

9.  Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population.

Authors:  Zhijun Feng; Ruili Qiao; Zhijian Ren; Xiaofeng Hou; Jie Feng; Xiaodong He; Dongdong Chen
Journal:  J Gastrointest Oncol       Date:  2020-04

Review 10.  The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.

Authors:  Asurayya Worrede; Stephen M Douglass; Ashani T Weeraratna
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.